(Total Views: 855)
Posted On: 04/18/2025 6:22:45 PM
Post# of 154731
In 2011, the FDA revoked Avastin's (Bevaziumab) approval as a treatment for Breast Cancer because clinical trials showed it didn't improve survival (OS) or quality of life...and exposed patients to potentially serious side effects.
Despite the revocation for Breast Cancer...Avastin remains approved for treating other cancers including colon, lung, kidney, and brain cancer.
The MCRC Trial start date?...recruitment?...how many sites?...would include 30 patients at 350MG...and 30 patients at 750MG...along with TAS-102....We wait breathlessly.
Despite the revocation for Breast Cancer...Avastin remains approved for treating other cancers including colon, lung, kidney, and brain cancer.
The MCRC Trial start date?...recruitment?...how many sites?...would include 30 patients at 350MG...and 30 patients at 750MG...along with TAS-102....We wait breathlessly.
(5)
(0)
